Heron Therapeutics Inc vs NIO Inc. — how do they compare? Heron Therapeutics Inc trades at $0.46 (market cap $91.46M), while NIO Inc. trades at $4.81 (market cap $12.55B). The key difference: NIO Inc. is far larger — about 137.2× Heron Therapeutics Inc's market cap. Which is the better fit depends on your goals.
| HRTX | NIO | |
|---|---|---|
Market Cap | $91.46M | $12.55B |
Sector | Health | Consumer Cyclical |
52-Week High | $1.96 | $7.89 |
52-Week Low | $0.39 | $4.44 |
Enterprise Value | $189.36M | $11.78B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NIO trades at $4.79, down 1.84% with bearish technical signals despite strong delivery growth. The company shows improving fundamentals with revenue reaching $87.49B in 2025 and narrowing losses, though it remains unprofitable with negative cash flow. Analyst sentiment is mixed with 54% buy ratings but technical indicators show selling pressure. Recent vehicle deliveries surged 62.9% year-over-year in June 2026, providing optimism for margin improvement.
NIO presents a high-risk opportunity with significant growth potential but persistent profitability challenges. The stock offers exposure to China's EV market expansion but faces execution risks and competitive pressures. While delivery momentum is strong, investors must weigh the company's cash burn against its market position and Goldman Sachs' recent upgrade to buy with $7 target.
Trailing returns across standard periods
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
Read more on NIO →